The interactions between hemodynamic and hormonal modifications during antidiuresis and antinatriuresis induced by positive end-expiratory pressure (PEEP) were studied in six patients under 15 cm H20 PEEP before PEEP and after the addition of lower body positive pressure (LBPP) 
The interactions between hemodynamic and hormonal modifications during antidiuresis and antinatriuresis induced by positive end-expiratory pressure (PEEP) were studied in six patients under 15 cm H20 PEEP before PEEP and after the addition of lower body positive pressure (LBPP) to PEEP (PEEP+LBPP). We measured or calculated the following: cardiac index, systemic arterial, right atrial, pulmonary arterial, and pulmonary artery occlusive pressures; indexed renal blood flow ( to collect the data, we selected patients mechanically ventilated for neurological reasons 23 + 6 days after the acute injury. The following criteria for preinclusion were used: normal lung, cardiac or renal function as assessed by routine clinical, radiologic, and biological tests with a mean serum creatinine clearance of 142 + 45 mL/min at that time; no administration of diuretic, analgesic, or antiinflammatory drugs before or throughout the study; hemodynamic stability as assessed by serial hemodynamic measurements: only patients with CO variations less than 15% in the 90 min of each step of the protocol were kept in the study. Three patients with the initial criteria for preinclusion were taken out of the study because CO variations were greater than 15%. Finally, six male patients, aged 35 ± 14.2 years old, were selected. None of them had cerebral edema or intracranial hematoma evidenced on a CT scan performed the day before the study. No patient had undergone any previous surgery, nor suffered from any fluid or electrolyte abnormality, including inappropriate ADH secretion. FIo2 (0.33 ± 0.05) was adapted to maintain PaO2 higher than 90 mm Hg throughout the procedure. To limit metabolic variations and hemodynamic instability during data collection, all patients were sedated by continuous intravenous infusion of flunitrazepam and were paralyzed with pancuronium bromide.
Hemodynamic Study: Systemic arterial pressure (SAP) was monitored via a radial artery catheter. Intraluminal right atrial (RAP), pulmonary artery (PAP), and pulmonary artery occlusive (PAoP) pressures were measured via a triple-lumen balloontipped Swan-Ganz catheter inserted into the pulmonary artery via the right internal jugular vein. Position of the catheter tip was verified by a chest x-ray film, which also confirmed the absence of radiologic abnormalities. All pressures were measured and averaged over one respiratory cycle with Bentley transducers positioned at the midaxillary level, connected to a Thomson Telco amplifier and to a multichannel recorder (Gould ES 1000). Heart rate (HR) was recorded from a standard ECG lead. (Ct) when measured with a gamma counter (Kontron, France) and plotted vs time on semilog paper. An aliquot of the injected dose also was measured, and the amount of injected counts per second was determined and designated qo. Radioactivity disappearance proved to be a biexponential function of time, and the second segment of the curve was used to calculate RPF as follows: RPF=K -VD, where K is the rate constant equal to 0.693/T'/2 and VD is the distribution volume.
Retrospective extrapolation of the second segment of the curve was used to determine concentration at time zero (t0,, ,Ci/mL). The injected dose qo was then divided by this latter value to determine the distribution volume VD=qo/Cto. The first intravenous bolus injection of '3'IPAH contained 50 ACi in 10 mL, and the second contained 150 ,Ci in 15 mL. Thus, total body irradiation was 5.4 x 10-2 mGy and kidney irradiation was 1.8 mGy.
Using each patient's hematocrit value, we calculated renal blood flow (RBF) according to the formula: RBF (mL-min-')= RPFX1/1-hematocrit. Total blood volume was measured using RBC tagged with a chromium radioisotope (5'Cr) at the beginning of the protocol and at the end of PEEP+LBPP measurements. Before this study, reproducibility of the RBF measurement technique had been assessed by three successive measurements performed in two healthy volunteers kept under stable hemodynamic conditions. Intraindividual variations were less than 8%.
Renal Function Study: Urine was collected through an intravesical catheter, and urinary output was expressed in mL min-. Blood and urine samples were drawn to determine the concentrations of urea, creatinine, and electrolytes using standard laboratory techniques. Osmolality was measured with a Fick osmometer. Creatinine clearance, free water clearance, and osmolal clearance were calculated and expressed in mL -min-'. Glomerular filtration rate (GFR) was evaluated as the creatinine clearance * filtration fraction was expressed in a percentage using the ratio GFR to RPF. The FE Na+ was calculated and expressed in a percentage.
Hormonal Study: Plasma ADH levels were determined by radioimmunoassay on venous blood samples drawn into chilled syringes containing dipotassium ethyleuadiaminetetraacetic acid. Blood samples were centrifuged at 3,000 revolutions per minute (rpm) for 15 min at +4°C, and plasma was stored at -20°C and extracted within 2 weeks with acetone. Plasma ADH was measured by radioimmunoassay. 18 The mean plasma ADH value observed in normal subjects under conditions of moderate antidiuresis was 3.6+ 0.16 (SEM) picogram (pg)/mL. Intraassay and interassay variations were 12.5 and 17.9%, respectively. The antibody used did not recognize oxytocin (Ocytocin) even at 1 ng/mL and cross-reacted slightly with 1-deamino-8-D-AVP (0.6%).
Plasma norepinephrine and epinephrine concentrations were measured using a double-isotope radioenzymatic assay.19 Pulmonary artery blood samples were collected in chilled tubes containing lithium heparin. After 20 min of centrifugation (4,000 rpm) at +40C, plasma was separated and stored at -20°C until the assay was done. Sensitivity of this technique was 1.5 pg/mL for both epinephrine and norepinephrine. Variation coefficients were 3.1% (420 + 13 pg/mL) and 3.3% (80 + 2.6 pg/mL) for intraassay and 4.2 and 4.5 for interassay for norepinephrine and epinephrine, respectively. Plasma renin activity (PRA) was determined on pulmonary arterial blood after centrifugation by CEA Sorin kit. The PRA measurement was based on the radioimmunoassay of angiotensin j20 and was expressed as nanogram of angiotensin I generated per milliliter of plasma per hour of incubation.
Urinary PGE2 concentration was measured by radioimmunoassay using the extraction and assay procedures previously described elsewhere.2' Results were expressed in picogram per milliliter. Urine (5 mL) was acidified to pH 3.0 to 3.5, extracted twice with 3 volumes of a solution of cyclohexane and ethylacetate in a ratio of 1 to 1, and chromatographed on silicic acid columns. Recoveries were calculated using ('3H) PGE2 additions to the original sample. Antiserum to PGE2 was obtained from Institut Pasteur, Paris. Standard curves were established for every assay, and all samples were assayed in triplicate. Fifty percent displacement of the radiolabeled PGE2 from the antibody was obtained with 10 pg PGE2. Recoveries varied from 50 to 80%. All values were corrected for the measured recoveries. Protocol
Two successive sets of measurements were performed, using the same sequence for all patients at the same level of fraction of inspired oxygen per patient. Baseline values were obtained at 15 cm H20 PEEP (PEEP), and mild LBPP was then added to PEEP (PEEP+LBPP). We used a classic anti-G suit device (Gladiator; Jobst, Ohio) inflated first around the lower limbs at 40 mm Hg, and then around the abdomen at 20 mm Hg to maintain a positive pressure gradient from the periphery to the heart.'5 Special attention was paid to avoid any compression of the lower thorax to conserve rib cage mechanics. An initial period of 30 min was first allowed to assess hemodynamic stability. After this initial 30-min steady-state period, a first intravenous bolus of '11IPAH was injected to measure RPF. After the '3'IPAH injection, PEEP ventilation was maintained during 90 min, at the end of which blood samples were collected and hemodynamic parameters, mean urinary output, and '35IPAH clearance were measured (PEEP). This sequence (30-min stabilization period followed by a 90-min acquisition period) was repeated when LBPP was added to PEEP (PEEP+LBPP).
Total blood volume was maintained at a stable level by exact compensation of urinary loss (455 + 50 mL) with 5% dextrose in water with 92 mEq/L sodium chloride. Stability of volemic status in the procedure was assessed by measuring blood volume before and after the data collection. Total duration of the protocol did not exceed 5 h, and we assumed that no significant evolution of the patients' clinical conditions occurred within this time.
Statistical Analysis
All data are expressed as mean ± SD. The raw and calculated data were compared by the paired t test. Linear correlations were calculated by the least squares method. A probability value less than 0.05 was considered statistically significant.
RESULTS

Systemic Hemodynamic and Gazometric Study
The HR and SAP did not vary under the two conditions of the protocol ( Table 1 ). The LBPP application during PEEP increased CI (p<0.001) and SI (p<0.001), via an increase in RAP and PAoP, with a consequent decrease in SVRI (p<0.02). Blood pH, PaCO2, and hematocrit values remained stable.
Renal Hemodynamic and Function
Total blood volume, serum electrolytes, and plasma osmolality did not change throughout the study (Table 2, Fig 1) . The PEEP-induced antidiuresis and antinatriuresis were sustained in PEEP+LBPP with no change in GFR.
The LBPP application increased indexed RBF (IRBF [p<O.O1]) with no change in RPP. Figure 1 shows the significant correlation between CI and IRBF in the two sets of measurements (r=0.85, p<O.OOl). Hormonal Study Plasma ADH concentrations were in the normal range according to plasma osmolality during PEEP ventilation and did not vary in PEEP+LBPP (Table  3 ). The PRA levels were elevated during PEEP ventilation and remained elevated after LBPP application. Plasma epinephrine values were within the normal range during PEEP and remained unchanged Alternations in renal function and in fluid balance during mechanical ventilation may constitute an adverse prognostic factor. Whatever the underlying disease or the ventilatory mode, increased intrathoracic pressure always induces antidiuresis and antinatriuresis.14 Several mechanisms have been proposed to explain the relationship between the increase in intrathoracic pressure and renal function alterations, including systemic or renal hemodynamic alterations or both," 6'7'8 reflex activation of the sympathetic outflow,4 increase in ADH secretionl0 or in plasma renin activity.6 However, the respective roles of systemic and renal hemodynamic modifications and their relationships with the release of vasoactive hormones as well as the exact stimulus of sympathetic outflow activation remain to be elucidated.
Systemic and Renal Hemodynamics
Few human studies have reported simultaneous measurements of systemic and renal hemodynamic parameters with control of total blood volume. Annat et a16 observed a parallel decrease in renal plasma flow, GFR, and CO and suggested that renal hemodynamic alteration induced by PEEP was a consequence of a decrease in CO. This hypothesis had been previously tested using plasma volume expansion to increase CO during PEEP,22 but conflicting results concerning an improvement in urine flow have been published.'0"14'22'23 It has been shown that dopamine improved urinary output,24 an effect that could result from renal vasodilation, from CO increase, or from both. But none of these studies showed a direct relationship between PEEP systemic hemodynamic alterations and renal hemodynamics and function.
The application of LBPP induced a significant in- results have been observed during renal hypoperfusion and ischemia. 34 The present data did not allow us to determine the impact of such prostaglandin release on renal hemodynamics and function nor its role on renin release, although PGE2 could have modulated the angiotensin-induced vasoconstriction. 34 However, the increase in urinary PGE2 release observed with LBPP failed to counterbalance antidiuresis and antinatriuresis.
In summary, this study showed that antidiuresis and antinatriuresis during PEEP were not entirely dependent on systemic and renal hemodynamic modifications. Moreover, deactivation of high and low pressure baroreflexes in this model did not relieve alterations in renal function. Whatever the stimuli, sustained high PRA and sympathetic outflow were the main factors contributing to failure of LBPP to correct water and sodium retention during PEEP ventilation. Further studies will be needed to elucidate the potential therapeutic benefit of converting enzyme inhibitors in this setting and to find out if the observed release of water and sodium retaining vasoactive hormones is appropriately counterbalanced by plasma atrial natriuretic factor secretion.
